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Abstract: During restricted time windows of postnatal life, called critical periods, neural circuits are
highly plastic and are shaped by environmental stimuli. In several mammalian brain areas, from the
cerebral cortex to the hippocampus and amygdala, the closure of the critical period is dependent on
the formation of perineuronal nets. Perineuronal nets are a condensed form of an extracellular matrix,
which surrounds the soma and proximal dendrites of subsets of neurons, enwrapping synaptic
terminals. Experimentally disrupting perineuronal nets in adult animals induces the reactivation of
critical period plasticity, pointing to a role of the perineuronal net as a molecular brake on plasticity
as the critical period closes. Interestingly, in the adult brain, the expression of perineuronal nets is
remarkably dynamic, changing its plasticity-associated conditions, including memory processes.
In this review, we aimed to address how perineuronal nets contribute to the maturation of brain
circuits and the regulation of adult brain plasticity and memory processes in physiological and
pathological conditions.
Keywords: perineuronal net; critical period; chondroitin sulfate proteoglycans; learning; memory;
Alzheimer’s disease; drug addiction
1. Introduction
During postnatal development the continuous interaction between the individual
and the environment affects the formation and refinement of neural networks. Neuronal
circuits that are activated by environmental stimuli are strengthened, whereas unused
synapses are eliminated. The experience-dependent shaping of neuronal connections
allows individuals to best adapt to the world around them. The ability of brain connections
to change in response to experience, i.e., plasticity, is particularly high during discrete time
windows of postnatal development, called critical periods. Different critical periods, each
one with its own timings, involve distinct brain regions across development. For example,
in many species, including humans, critical periods exist for the development of sensory
systems, vocal behavior, cognitive functions, and emotional traits. The development of
higher functions, such as language, may depend on the proper temporal alignment of
critical periods for the development of lower functions [1]. Since the pioneering studies by
Hubel and Wiesel in the 1960s, the best-characterized model of critical period plasticity
is ocular dominance (OD) plasticity. In the adult primary visual cortex, neurons that
respond preferentially to inputs from one eye or the other are organized in alternating
stripes that run perpendicularly to the cortical surface (so-called OD columns). During
the critical period for OD plasticity, geniculocortical afferents serving the two eyes are
initially completely overlapping, and only an activity-driven competition between the two
eyes leads to the subsequent segregation of the afferents in separate columns. However,
if inputs from one eye are reduced (due for instance to strabismus, congenital cataract or
other conditions of monocular deprivation), there is a shift in the responsiveness of visual
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cortex neurons toward the dominant eye, with the concomitant remodeling of cortical
dendritic spines and thalamic axons, which is accompanied by a loss of visual acuity in the
weaker eye [2–6]. These deficits are permanent if monocular deprivation is not corrected
before the closure of the critical period. In fact, the end of critical periods brings about a
progressive stabilization of synaptic connections and, consequently, a drastic reduction in
brain plastic abilities. Experiments in the visual system made it clear that critical periods
can also represent a time of vulnerability for the developing brain. If aberrant or deficient
stimuli are experienced, maladaptive plasticity takes place and adverse sensory outcomes
manifest with lifelong consequences. This also holds true for the consequences of early-life
adversity (e.g., childhood trauma, stress, impoverished care) on the risk of developing
cognitive deficits or psychopathologies in adult individuals [7].
The onset and closure of critical periods are strictly controlled by a number of molecu-
lar and cellular mechanisms. In primary sensory areas the onset for plasticity is triggered
by a change in the balance between excitation and inhibition. This change is mainly due to
the maturation of intracortical GABAergic neurons, especially fast-spiking, parvalbumin-
expressing (PV+) basket cells. These neurons, which form a highly interconnected network,
inhibit nearby pyramidal cells and generate gamma frequency rhythmic oscillations, which
are important for information processing. Notably, PV circuits mature at different times
across brain regions, contributing to a sequential appearance of critical periods. Although
the maturation of PV cells depends on an intrinsic genetic program [8,9], it is sensitive to
experience. Dark rearing disrupts the maturation of inhibitory circuits [10], whereas en-
riched environmental stimulation accelerates it [11–13]. Neural activity drives the release of
developmental regulators, which promote PV neuron maturation, including brain-derived
neurotrophic factor (BDNF) [14], neuronal pentraxins (NARP) [15], neuregulins [16], and
orthodenticle homeobox 2 (Otx2) [17].
Several mechanisms are involved in the termination of a critical period. One mech-
anism that stands out is the formation of perineuronal nets (PNNs). In this review, we
address the role of PNNs in restricting critical period plasticity. Next, we discuss the
modulation of PNNs during adult brain plasticity, including learning and memory. Finally,
we describe the involvement of PNNs in memory-related diseases, including Alzheimer’s
disease and drug addiction.
2. PNNs and Brain Maturation
2.1. Distribution of PNNs
PNNs are condensed aggregates of an extracellular matrix (ECM) enwrapping the cell
body, dendrites, and axon initial segments of several neurons in the adult central nervous
system (CNS). They represent one form of an ECM in the CNS, together with the ECM
that is loosely distributed in the parenchyma, the ECM that constitutes the basal lamina
(which separates the CNS tissue from meningeal and vascular tissues), and the ECM that is
located at the nodes of Ranvier [18]. The PNN coating is interrupted by holes, in which
synaptic boutons are contained (see Figure 1A,B for representative pictures of PNNs in the
mouse cerebellar nuclei that enwrap GABAergic terminals).
Therefore, these synapses can be viewed as a tetrapartite structure, comprising the
presynaptic terminal, the postsynaptic element, astrocytic processes, and the PNN [19].
PNNs are found around distinct classes of inhibitory and excitatory neurons throughout
the rostrocaudal axis of the CNS of vertebrates, from the cortex to the spinal cord. PNNs
are particularly well developed in birds and mammals. In the latter class, PNNs have been
described in several species, including mice, rats, guinea pigs, gerbils, cats, dogs, sheep,
monkeys, and humans. Examples of PNN-bearing neurons in rodents are GABAergic
PV+ neurons in the cortex, interneurons, and pyramidal neurons in the hippocampus; PV-
positive and negative neurons in the striatum; excitatory neurons in the cerebellar nuclei;
motoneurons and interneurons in the spinal cord [20–35]. Notably, species-dependent
differences exist with respect to whether PNNs surround the inhibitory or excitatory
neurons. Although in rodents, the majority of PNN-enwrapped neurons in the cortex are
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PV+ GABAergic neurons, in primates, a substantial number of pyramidal neurons in the
motor and somatosensory cortex bear a PNN [24,36,37]. In the basolateral amygdala of
rats, PNNs are found around PV+ and PV− neurons, while in mice, they are reported only
around excitatory neurons [38,39]. The common denominator of all different types of PNN-
bearing neurons seems to be their fast-spiking neuronal activity. Thus, PNNs are proposed
to serve as extracellular reservoirs for physiologically relevant cations, such as Ca2+, K+,
or Na+, contributing to fast and precise neuronal transmission [40]. Indeed, through ionic
interactions, polyanionic components of PNNs are able to reversibly accumulate cationic
molecules at physiological concentrations, potentially contributing to local molecular
gradients of ions [41]. The “anionic shield” made by the PNN may also represent a
protective mechanism against toxic species that are generated by metabolic or oxidative
stress, as discussed later.




Figure 1. Structure and composition of the PNN. (A) and (B) show PNNs around neurons in the 
mouse cerebellar nuclei, labelled by Wisteria floribunda agglutinin (WFA), in green. PNNs display 
their typical holes, in which pre-synaptic terminals are contained. In (A), GABAergic terminals are 
shown (in red), labelled by anti-VGAT antibodies. In (B), post-synaptic clusters of gephyrin, which 
anchors GABA receptors to the underlying cytoskeleton, are shown (in red). In (C), the main mo-
lecular components of PNNs are depicted. Scale bar: 4 µm in A and B. 
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2.2. Composition of the PNN 
PNNs are primarily composed of hyaluronan, chondroitin sulfate proteoglycans 
(CSPGs), link proteins and tenascin-R. Hyaluronan can be considered the backbone of the 
PNN structure (Figure 1C). It is a large polymer of disaccharide units (made of N-acetyl-
glucosamine and glucuronic acid), to which CSPGs can bind [42]. Hyaluronan is synthe-
sized by hyaluronan synthases (HAS). These are plasma membrane-bound enzymes, 
mainly expressed by neurons, which extrude hyaluronan into the extracellular space. 
While being synthesized, hyaluronan can be kept anchored to the cell surface via the HASs 
[27,43]. HAS may thus represent the anchoring sites of the PNN to the neuronal mem-
brane, although the hyaluronan receptor CD-44, which is mainly expressed by astrocytes 
Figure 1. Structure and composition of the PNN. (A,B) show PNNs around neurons in the mouse cerebellar nuclei, labelled
by Wisteria floribunda agglutinin (WFA), in green. PNNs display their typical holes, in which pre-synaptic terminals are
contained. In (A), GABAergic terminals are shown (in red), labelled by anti-VGAT antibodies. In (B), post-synaptic clusters
of gephyrin, which anchors GABA receptors to the underlying cytoskeleton, are shown (in red). In (C), the ain molecular
components of PNNs are depicted. Scale bar: 4 µm in (A,B).
2.2. Composition of the PNN
PNNs are primarily composed of hyaluronan, chondroitin sulfate proteoglycans
(CSPGs), link proteins and tenascin-R. Hyaluronan can be considered the backbone of
the PNN structure (Figure 1C). It is a large polymer of disaccharide units (made of N-
acetylglucosamine and glucuronic acid), to which CSPGs can bind [42]. Hyaluronan is
synthesized by hyaluronan synthases (HAS). These are plasma membrane-bound enzymes,
mainly expressed by neurons, which extrude hyaluronan into the extracellular space. While
being synthesized, hyaluronan can be kept a chored to the cell surface via the HASs [27,43].
HAS may thus r present the anchori g sites of the PNN to the neuronal membrane,
although the hyaluronan receptor CD-44, which is mainly expresse by astrocytes [44],
may also contribute to keeping the PNN in place near the synapses. Three HAS isoforms
exist (HAS-1, -2, -3), the expression of which varies depending on the CNS region and
develo mental time point [27,29,45]. Hyaluronan is crucial for PNN assembly, as shown
by the mplet removal of PNNs following the administration of hyaluronidase [46–48].
CSPGs bind to hyaluronan (via their N-terminal dom in) and consist of a core protein
and a n mber of chondroitin sulfate glycosaminoglycan chains (CS-GAG) attached to it.
The CSPGs found in the PNN are the members of the lec icans family (agg can, neurocan,
brevican, versican) and receptor protein tyrosine phosphatase zeta (RPTPζ)/phosphacan.
They are synthesized by neurons and/or glial cells [27,29,49]. Depending on which CSPGs
are prese t, heterogeneity in the PNN composition exists within and between CNS re-
gions [26,29], alt ough aggrecan seems to be present in the majority of the PNNs. CS-
GAG are made of alternating disaccharide units of N-acetylgalactosamine (GalNAc) and
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glucuronic acid, which can be nonsulfated or sulfated at various positions, typically in
position 2 of glucuronic acid and position 6 of GalNAc (CS-D), positions 4 and 6 of GalNAc
(CS-E), position 4 of GalNAc (CS-A), or position 6 of GalNAc (CS-C) [50]. By affecting
the charge properties of the CS chains and therefore their binding properties, different
patterns of sulfation significantly impact CSPG function. Interestingly, the sulfation pattern
of CS-GAG in the PNN differs from those of the diffuse matrix, giving PNNs unique
binding properties [46,51,52]. However, there is also diversity in the sulfation pattern of
different PNNs [53]. Moreover, the pattern of the CS sulfation changes considerably over
development. While most of the CS is 6-sulfated in the embryonic brain, at birth, only 18%
of the CS is 6-sulfated and 60% are 4-sulfated. These amounts change again after the end of
the critical period, when 2% of the CS is 6-sulfated and 91% is 4-sulfated [46,54,55]. In the
aged rodent brain, most of the remaining 6-sulfation is removed [56]. These differences
are important because CS-A and CS-C have distinct binding properties and influence
axon growth and plasticity in opposite ways, with CS-C promoting it and CS-A inhibiting
it [51,57–59]. Notably, the sulfation pattern of PNN CS-GAGs is different from that of the
general brain matrix. For instance, CS-E, which is very inhibitory to axon growth, repre-
sents 1.4% of the CS in the diffuse ECM and 2.1% in the PNNs [46]. CS-E can also bind some
growth and plasticity regulators, including semaphorin 3A (Sema3A) and orthodenticle
homeobox 2 (Otx2) [60–63].
Link proteins stabilize the binding between CSPGs and hyaluronan (Figure 1C). The
link protein family comprises four members, with three of them expressed in the CNS: carti-
lage link protein-1/Hapln1, brain link protein-1 (Bral1)/Hapln2 and Bral2/Hapln4 [64–67].
Cartilage link protein-1 and Bral2 are expressed in PNNs, whereas Bral1 is abundant in the
ECM surrounding the nodes of Ranvier [68].
The lecticans are linked to each other via the trimeric glycoprotein tenascin-R, which
binds to the lectican C-terminal domain [69] (Figure 1C). As demonstrated by the reduced
or diffuse expression of several PNN components in adult mice lacking tenascin-R, this
molecule plays a crucial role in PNN assembly [70,71].
PNNs are formed during postnatal development. However, many PNN components,
particularly hyaluronan and CSPGs, are expressed at embryonic or postnatal stages when
PNNs have not yet developed [72–74]. What brings them together to form a PNN? Analysis
of the temporal and spatial distribution of major PNN components at the mRNA and
protein levels revealed that link proteins might fulfill the role of PNN organizers, being
expressed in neurons surrounded by PNNs exactly at the time of PNN formation [27,55,74].
In vitro experiments helped unveil which components of PNNs trigger PNN formation.
By using a non-neuronal cell line (human embryonic kidney 293T cells) that does not
produce a discrete pericellular matrix, it has been shown that the cells are able to produce a
pericellular HA coat when overexpressing HAS3. Moreover, HA condenses into a compact
matrix when cells also produce both cartilage link protein 1 and aggrecan [43]. In vivo
experiments confirmed these findings. In mice lacking cartilage link protein 1 in the CNS,
the formation of an organized PNN structure is compromised, although the overall amount
of brain CSPGs is unchanged, pointing to a role of cartilage link protein 1 in gathering PNN
components [55]. Intriguingly, in the absence of Bral2, PNNs show a substantial reduction
of brevican but no changes in aggrecan expression, which indicates that the binding of
aggrecan in the PNN does not depend on Bral2 [75]. Based on this and other evidence, it
has been proposed that distinct link proteins regulate the micro-organization of PNN via
specific interactions with lecticans, e.g., Bral2 with brevican and cartilage link protein 1
with other lecticans [68].
A brain-wide developmental knockout of aggrecan, as well as acute knockout in the
adult brain, resulted in impaired aggregation of lecticans and link proteins into PNNs, sug-
gesting that aggrecan is essential for PNN formation and maintenance [76]. Recently, it was
shown that phosphacan, the secreted variant of RPTPζ (also known as RPTPβ) is critical
for PNN formation [77]. RPTPζ and phosphacan are expressed by glial cells and neurons
throughout the developing and adult nervous system [78,79]. In knockout mice without
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RPTPζ, PNNs lose their typical Wisteria floribunda agglutinin positive (WFA+)/aggrecan+
lattice-like appearance, displaying discontinuous accumulations of WFA/aggrecan. In-
triguingly, phosphacan is shown to serve as an anchor of the PNN to the neuronal surface,
although its putative receptor is still unknown [77]. Regarding the other CSPGs contained
in PNNs, studies in knockout mice show that neurocan and brevican are largely dispens-
able for PNN formation [80,81]. However, PNN formation in quadruple knockout mice
lacking neurocan, brevican, tenascin-R and tenascin-C is significantly delayed in the CA2
in vivo and strongly compromised around primary hippocampal neurons [82–84].
In conclusion, the genetic manipulation of PNN components point to link proteins
and aggrecan as key molecules for the assembly and accumulation of a fully organized
PNN around neurons, which requires tenascin-R and phosphacan for further stabilization.
Functional studies confirm the importance of these molecules for PNN formation. Indeed,
in mice lacking cartilage link protein-1 or aggrecan juvenile levels of plasticity persist
throughout adulthood (see Section 2.3), and in tenascin-R knockout mice increased axonal
plasticity after injury is observed [85].
The formation of PNNs depends on neuronal activity. Rearing animals in darkness
from birth prevents PNN formation in the adult visual cortex. Reintroducing dark-reared
animals into a normal light/dark cycle enables PNN restoration, which is accompanied by
the upregulation of cartilage link protein 1 and aggrecan [55,86]. Sensory deprivation in
the mouse somatosensory cortex obtained by trimming whiskers from the early postnatal
days till adulthood results in decreased PNNs in adult mice [87,88]. Sensory information is
also indispensable for PNN development in the spinal cord [89] and the primary auditory
cortex [90].
An interesting feature of PNNs during brain development is the change in their
morphological organization, from a granular-like pattern in the early postnatal period to
a reticular-like pattern later on [88]. Although the functional difference between these
patterns is not known, it can be hypothesized that granular-like PNNs may have a weak
control on synaptic stability, the maintenance of ion homeostasis, and the repulsion of
incoming synapses. Interestingly, WFA+ PNNs also appear as granular structures in
prefrontal areas of the adult brain [91], which are highly plastic regions [92]. These less
condensed PNNs resemble those of mice lacking tenascin-R, which is not detected in the
PNNs of the prefrontal cortex [91]. The shift during development from a more disconnected
to a more continuous net structure has been shown in detail by Sigal et al. [93] in the mouse
primary visual cortex by using super-resolution microscopy. Furthermore, PNNs are
granular in short-term neuronal cultures (<14 days in vitro) and become more reticular
upon maturation [94]. Based on concepts of soft matter physics, it has been proposed that
the relative abundance of hyaluronan, CSPGs, link proteins, and tenascin-R, as well as
their interactions, would determine the degree of matrix compaction, rigidification, and
stabilization. Several PNN parameters, such as the size, sulphation, and abundance of
CSPGs, the size and number of hyaluronan chains, and/or the abundance of crosslinking
molecules, gradually change during CNS maturation, and may thus dictate the structural
organization of the PNN [94].
2.3. PNNs and the Regulation of Critical Periods
The time of maturation of PNNs coincides with the closure of critical periods in many
brain regions. This is apparent in mammalian species, where for instance PNNs are formed
at the end of the critical period for ocular dominance plasticity in the visual cortex [86],
for the erasure of fear memories in the amygdala [95], for barrel cortex plasticity induced
by univibrissa rearing [96], and for leptin-sensitivity of hypothalamic arcuate nucleus
neurons that regulate food intake and energy metabolism [34]. Likewise, PNNs mature in
song nuclei in birds in parallel with the end of the critical period for sensorimotor vocal
learning [97–99]. The idea that PNNs actually contribute to the end of critical periods came
when it was shown that the digestion of CS-GAGs by the enzyme chondroitinase ABC
(ChABC) restores critical period-like levels of plasticity in the adult CNS (see Box 1 for
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an historical summary of key studies on PNNs). Particularly, the injection of ChABC in
the adult visual cortex induces the reactivation of ocular dominance plasticity [86,100].
Those studies were followed by many others, which demonstrated increased plasticity in
several CNS areas upon the digestion of CS-GAG (reviewed in [101]). However, direct
proof was still missing showing that it is the PNNs, rather than the other forms of ECM,
that restrict plasticity at the end of the critical period, especially when taking into account
that 98% of CSPGs in the CNS are present in the diffuse ECM and only 2% are in PNNs [46].
Experiments on mice with defective PNNs, namely mice lacking cartilage link protein-1 or
aggrecan, showed that these animals have vestigial PNNs and display persistent ocular
dominance plasticity in adulthood, which is indicative of a prolonged critical period [55,76].
PNNs and their CS-GAG chains are thus responsible for dictating the timing of the critical
period closure.
Interestingly, PNNs contribute to the end of critical periods for development, not
only of sensory systems but also of memory systems, such as those underlying memories
of experiences that evoked an emotional reaction (emotional memories). One example
of emotional memory is fear conditioning. Animals show a freezing response (which is
a sign of fear) to a painful stimulus, such as a foot shock. After repetitively pairing a
neutral stimulus, which can be a particular context or a cue (conditioned stimulus), with
the foot shock (unconditioned stimulus), animals learn that the neutral stimulus predicts
the occurrence of the aversive one and freeze when presented with the neutral stimulus. If
an extinction training is then performed, namely, only the neutral stimulus is presented, a
decrease in freezing occurs with time. During early postnatal development, the extinction
of conditioned fear leads to memory erasure (infantile amnesia), whereas in adult animals,
fear conditioning memory is resilient to erasure by extinction (after some time, the fear
response can be reinstated by the presentation of the conditioned stimulus). Interestingly,
the appearance of PNNs in the amygdala is responsible for the transition from erasure-
prone to erasure-resistant fear extinction. The digestion of PNNs in the adult amygdala by
ChABC reopens a critical period for erasure-like extinction [95], suggesting that PNNs may
contribute to the synapse consolidation underlying fear memory retention.
In recent years, our knowledge of a link between PNNs and the control of a critical
period for emotional, cognitive, and social behaviors has expanded. Exposure to early life
adversity is known to alter neural development in brain regions that are implicated in
emotion regulation, cognitive functions, and social interactions, increasing the susceptibility
to developing neuropsychiatric disorders in adulthood, including depression, anxiety, drug
abuse, and schizophrenia (for reviews, see [102,103]). Interestingly, early-life adverse
experiences have been associated with aberrant PNN density and intensity in the adult
prefrontal cortex [104], basolateral amygdala [105], and hippocampus [106,107], suggesting
that early life stress affects PNN organization throughout the brain. It is also noteworthy
that infant rats reared in stressful conditions exhibit longer retention of fear memories than
standard-reared rats (for a review, see [7]), where this is accompanied by earlier maturation
of GABAergic neurons and PNNs in the amygdala in male individuals [108].
The role of PNNs in hippocampal development is less clear, particularly because the
hippocampus is a complex brain region, and its subdivisions might have different time
windows for critical periods. A critical period for the development of the hippocampus
has been studied in relation to its sensitivity to iron deficiency. As shown in human
and animal models, early life iron deficiency results in long-term learning and memory
deficits [109–112], as well as abnormal dendritic morphology and a reduced number of PV
cells and PNNs in the CA1 [113–115]. If iron is replenished in mice from P21, the behavioral
and morphological consequences of early life iron deficiency are normalized, but this does
not occur if the iron is replenished from P42, pointing to a hippocampal critical period
for sensitivity to iron deficiency, which ends between P21 and P42 [115]. The work by
Umemori et al. [116] showed the increased formation of PNNs in the CA1 and dentate gyrus
at P24 when compared to P17, and suggested that at P24, the critical periods of those brain
regions are closing. Interestingly, PNNs in the CA1 and dentate gyrus at P24 are decreased
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following perinatal exposure to the selective serotonin reuptake inhibitor fluoxetine [116],
which is an anti-depressant that is approved for use during pregnancy and lactation
that can, however, represent chemical stress for the developing fetus. Adult rats that
received fluoxetine perinatally exhibited depression-like behaviors [117]. Overall, delayed
maturation of PNNs in the CA1 might be responsible for long-lasting cognitive/psychiatric
impairments. The hippocampal area CA2 is required for the formation of social memories,
and particularly social recognition memory, namely the ability to recognize a novel or
familiar conspecific [118]. The CA2 contains a population of large pyramidal neurons [119],
which are surrounded by prominent PNNs. Similar to other brain regions, in the CA2,
PNN formation is experience-dependent [32]. The digestion of adult PNNs results in
the enhanced synaptic potentiation of excitatory synapses on CA2 neurons, raising the
possibility that PNNs control a critical period for CA2 synaptic plasticity and related
behavior [32].
How do PNNs restrict plasticity? CSPGs can bind effector molecules, exposing them
to their receptors, or can mediate the uptake of regulatory molecules by neurons. Two
molecules have recently been discovered as CS-GAG-binding molecules, which represent
examples of either mechanism of action: Sema3A and Otx2 (Figure 1C). Best known for
its role as a chemorepulsive axon guidance protein during nervous system development,
Sema3A is also abundantly expressed by neurons throughout the adult CNS [120], where it
is localized to the CSPGs in PNNs [121]. It can bind with high affinity to CS-E motifs [63],
although recent evidence points to a strong affinity of Sema3A for nonsulfated GalNAc
residues of CS chains [122] and CS-A [123]. In the visual cortex, Sema3A accumulates
in PNNs in coincidence with the closure of the critical period, where this accumulation
is experience dependent. Interestingly, in adult rats, dampening Sema3A signaling by
overexpressing an inactive Sema3A receptor restores juvenile levels of ocular dominance
plasticity [124]. These data indicate that Sema3A contributes to PNN-mediated restriction
of plasticity at the end of a critical period. The exact mechanism of how Sema3A exerts its
effects is not known. During development, Sema3A requires a receptor complex that is com-
posed of neuropilin-1 and plexinAs to achieve repulsive guidance signaling. Neuropilin-1
binds to Sema3A and plexin and is essential for the stabilization of the Sema3A–plexin
interaction [125]. Sema3A receptors plexinA1 and lexinA4 are also expressed in adult
neurons [126]. In the cerebellar nuclei, where strong perineuronal Sema3A is present,
both nuclear neurons and their pre-synaptic afferents, the Purkinje cell axons, express
the Sema3A receptor component plexinA1 and 4 [126,127]. Neuropilin-1 is strongly ex-
pressed in the molecular layer of the dentate gyrus, where entorhinal stellate neurons
project their axons [128]. PlexinAs are also found on the membrane of PV neurons [121].
It can be hypothesized that by interacting with its receptors on the plasma membrane
of a postsynaptic neuron, Sema3A captured in PNNs may have an effect on the neuron
itself. For instance, Sema3A signaling may cause cytoskeletal changes, which may affect
the distribution of postsynaptic receptors, and thus, neuron plasticity and/or connectivity.
Another mechanism of action may involve Sema3A signaling in presynaptic terminals.
Sema3A that gradually accumulates in PNN may repel incoming Sema3A-sensitive axons,
thus preventing them from forming synapses on PNN-bearing neurons. During adulthood,
Sema3A in PNNs could stabilize existing synapses on the postsynaptic neuron. Finally,
because it has been shown that Sema3A is able to rigidify CS-E-based matrices, it may
cross-link PNN-GAGs, stabilizing the PNN structure [129].
The cellular source of the Sema3A protein in PNN is not entirely clear. Sema3A
mRNA is detected in many neurons throughout the CNS [120]. Sema3A-positive PNNs
can be found around both neurons that express Sema3A mRNA and neurons that do
not. In cultured neurons, Sema3A is actively transported in vesicles through the axon
and dendrites, and in axons, it is transported in an anterograde direction in an activity-
dependent manner [130]. Sema3A protein might thus be produced by neurons, transported
to their terminals, and then deposited in the PNN around postsynaptic neurons. In addition,
Sema3A is expressed by choroid plexus cells (our unpublished observations) and meningeal
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cells [131]. Sema3A may be released by cells of the choroid plexus or meninges in the
cerebrospinal fluid and travel through the brain parenchyma to bind to PNNs.
Otx2 is a homeoprotein transcription factor that controls the regionalization of the
vertebrate brain during embryonic development. Like many homeobox proteins, it can be
transferred between cells. During cortical postnatal development, Otx2 is preferentially
internalized by PV cells and promotes their maturation, consequently regulating the onset
of a critical period [17,132]. Interestingly, CS-GAG of the PNN, and particularly CS-D and
CS-E, participate in the specific recognition of Otx2 before its internalization, interacting
with a short motif containing an arginine–lysine (RK) doublet within the Otx2 sequence [60].
Moreover, Otx2 is required for PNN assembly during the critical period. When the amount
of Otx2 is genetically reduced or the GAG-recognition motif of Otx2 is mutated, mice show
a delay in the maturation of the PNNs and the critical period onset across several cortical
areas [17,132]. The infusion of Otx2 in the visual cortex before the onset of the critical period
or in animals reared in darkness accelerates PNN formation, as well as both the onset and
the end of the critical period [17]. In addition, injection of the RK peptide in the adult
mouse visual cortex induces a reduction of Otx2 accumulation in PV+ neurons, a decrease
in PV and WFA staining, and an increase in visual cortex plasticity [60]. Similar results are
obtained when Otx2 transfer in PV cells is blocked by infusing a synthetic CS-E analog
in the adult cortex [62]. Accordingly, blocking Otx2 internalization into PNN-bearing
neurons in the adult visual cortex leads to a reduction in WFA+ PNNs and a restoration
of juvenile levels of plasticity [133]. In addition, mice in which the binding of Otx2 to
PNN was genetically reduced show increased plasticity in adult cortical areas, in parallel
with the reduced PNN accumulation [132]. In the adult brain, one of the main sources
of cortical Otx2 is the choroid plexus [134,135]. Knocking-down Otx2 specifically in the
choroid plexus decreases Otx2 cortical content and results in reduced PV expression and
PNN assembly, as well as increased plasticity. Therefore, Otx2 is a crucial molecule for
maintaining the PNNs in a mature state and restricting adult plasticity in sensory systems.
The mechanisms through which Otx2 regulates PNN maturation and maintenance are
largely unknown. Recently, an association between Otx2 and aggrecan mRNA has been
found, suggesting that aggrecan expression may be post-transcriptionally promoted by
Otx2 [136]. Moreover, Gadd45b/g have been identified as direct targets of Otx2. The
Gadd45 family has been implicated in epigenetic gene activation [137–139], which can
impact plasticity [140,141]. Gadd45b/g cortical expression increases during the cortical
critical period and declines as plasticity is turned off, and is apparent in cells that internalize
Otx2. Gadd45b induces the upregulation of a number of genes that are associated with
plasticity, including Arc, Fos, Egr2, and Egr4, possibly by triggering changes in the DNA
methylation of these genes. Therefore, in adults, Otx2 may induce the downregulation of
plasticity genes by suppressing the expression of Gadd45b [142].
The role of Otx2 in the maturation and plasticity of other systems, such as those
regulating emotions or learning and memory, is still unknown. Because Otx2 may poten-
tially reach PNN-bearing neurons in the whole brain via the cerebrospinal fluid, it may
contribute to the orchestration of critical periods underlying different behaviors.
Several other growth factors bind with high affinity to CS-GAGs. These molecules
include nerve growth factor, BDNF, neurotrophin 3, midkine, pleiotrophin, hepatocyte
growth factor, and fibroblast growth factor 2 [143,144]. However, it is not known whether
they interact specifically with CS-GAGs in PNNs. CSPGs also associate with cell adhe-
sion molecules, such as the neural cell adhesion molecule (NCAM), the neuron–glia cell
adhesion molecule (NG-CAM), and contactin [52,145]. Interestingly, the neurocan inter-
action with NCAM impairs the association between NCAM and ephrin type-A receptor
3, and thus, the activation of ephrin type-A receptor 3 signaling, which is responsible for
the repulsion of GABAergic synapses on pyramidal cortical neurons. This points to a
role for the neurocan–NCAM association in synapse stabilization [146]. Furthermore, the
enzymatic digestion of CSPGs in the general perisynaptic matrix affects dendritic spine
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motility through an integrin-related mechanism [147,148], where integrins can inactivate
CSPGs [149]. However, this mechanism has not been explored for PNN-CSPGs.
Interestingly, the PNN component brevican directly regulates the localization of
potassium channels and the levels of synaptic AMPA receptors, as well as the maturation
of excitatory inputs into PV cells. In the absence of brevican, GluA1 subunits of AMPA
receptors fail to cluster in postsynaptic densities, where this may underlie the loss of
excitatory synaptic contacts onto PV+ interneurons [150]. Similarly, hyaluronan digestion
increases the movement of AMPA receptors between synaptic and extrasynaptic domains,
allowing for a faster replacement of desensitized receptors by naïve functional ones, thus
impacting short-term synaptic plasticity [151]. For a detailed review of the effects of the
ECM on synaptic properties see [19,152].
CSPGs can also exert their effects through their binding to specific receptors. CSPG
receptors have been discovered in the context of CNS injury, where CSPGs are upregulated
in the glial scar and inhibit axon regeneration. These receptors include receptor-type
tyrosine-protein phosphatase S (PTPRS; also known as PTPσ), leukocyte common antigen-
related phosphatase (LAR) [153,154], and Nogo receptor-1 and -3 [155]. However, a role
for these receptors in PNN functions has yet to be elucidated.
Box 1. An historical view of the PNN.
PNNs were first observed in 1898 by Camillo Golgi after using a slightly modified version of the
silver impregnation technique developed by him. They were described as a “delicate covering
around nerve cells, made of a substance that is clearly distinct from the cell body structure, and that
appears like a reticular structure, a continuous envelop, or made of contiguous little tiles; mainly
looking like a chain mail armor, it enwraps the cell body as well as protoplasmic prolongments up
to second and third order arborizations” [156]. A few years later Ramón y Cajal argued that PNNs
were artefacts deriving from the coagulation of substances dissolved in pericellular fluids [157],
thus discouraging further research in the field for many decades. In the 1960s periodic-acid-Schiff
(PAS) positive components have been observed around neurons [158]. PAS staining is used to
reveal polysaccharides [159]; however, at that time the similarities were not seen between the
PAS-positive material and Golgi’s finding. In the 1980s and 1990s, thanks to advances in the field
of histochemistry PNNs were undeniably visualized, and interest in these structures was sparked
again. The use of plant lectins, such as Wisteria floribunda agglutinin (WFA), Vicia villosa agglutinin
and soy bean agglutinin, all capable of binding to N-acetylgalactosamine residues [160,161]; the use
of colloidal iron hydroxide, for detection of negatively or positively charged components [162]; and
the use of monoclonal and polyclonal antibodies to CSPGs [36] were all instrumental to further our
understanding of the PNN structure. WFA is still widely used as a general marker for PNN-CS,
binding non-sulfated GalNAc residues [122]. Immunohistochemical and in situ hybridization
studies provided more insight into the molecular composition of PNNs and the cellular origin of
PNN components [27,29,49]. At the beginning of the 21st century the seminal work of J. Fawcett
(University of Cambridge, UK), T. Pizzorusso and L. Maffei (CNR, Pisa, Italy) implicated the PNNs
as crucial regulators of plasticity [86]. Since then, studies on PNNs have proliferated at a fast pace
(out of 642 total articles, 562 were published since 2002—Pubmed search), unveiling new PNN
components, properties and functions. For an historical timeline of research on PNNs, see Figure 2.
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3. P s and the ature rain
3.1. P yna ics and rain hysiology
s e discussed in the previous section, the aturation of P s dictates the end of
the critical period for plasticity in a number of brain regions, reducing the ability of new ex-
periences to leave a permanent trace in the brain and maximizing the storage of previously
acquired information. However, PNNs must not be viewed as static structures (Figure 3).
There are several examples of changes in PNN structure and number in concomitance with
episodes of neuronal plasticity in the adult brain. For instance, when adult mice or rats
are exposed to enriched environmental stimulation that provides enhanced social stimuli,
sensory inputs, and motor activity, ocular dominance plasticity is restored, learning perfor-
mance is improved, hippocampal neurogenesis is increased, and neuritic rearrangements
occur in several brain regions [163–166]. Intriguingly, PNNs throughout the brain are
reduced in animals exposed to enriched environmental stimulation [150,163,164,167]. The
effects of an enriched environment on PNN expression in the spinal cord are opposite to
those observed in the brain, as it causes an increase in PNN thickness [167]. Therefore,
enhanced levels of activity, while decreasing PNNs to boost plasticity in the brain, may
increase PNNs in the spinal cord to make spinal cord connections more stable and thus
ensure efficient output.
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Figure 3. Dynamics of PNNs. The scheme shows that PNN components accumulate and gather
around the cell body, proximal dendrites and axon initial segment of a neuron during postnatal
development. However, once formed, the PNN is not a static structure. In the adult brain PNNs
are reduced, for instance, during learning, and restored when the learning phase is terminated and
memories are consolidated.
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Another example of PNN dynamics is observed in the hypothalamus. Strong atten-
uation of PNN-associated phosphacan is observed around vasopressin+ magnocellular
neurons of the rat supraoptic neurons in response to salt loading [168], which triggers
dramatic structural plasticity in that area, including neuron hypertrophy, the juxtaposition
of somata and dendrites, the retraction of astrocytic processes, and synaptic sprouting [169].
Upon the cessation of salt loading stimulation, phosphacan expression is restored to basal
values and structural changes are reversed. Again, in this system, there is a tight correlation
between PNN expression and the levels of plasticity.
There is a strong link between serotonin levels and plasticity. Increasing serotonin
levels via fluoxetine administration results in enhanced plasticity in the adult visual cortex,
hippocampus, and medial prefrontal cortex. This is associated with reduced intracortical
inhibition and PNNs [170–172]. When the GABA tone is pharmacologically reduced in the
visual cortex of adult mice, ocular dominance plasticity is enhanced and the expression
of PNNs is diminished, indicating that a mature level of cortical inhibition limits adult
cortical plasticity [173].
Interestingly, very rapid changes in PNN CS-GAGs (i.e., within 24 h) occur in mouse
brain regions involved in emotional memory, where these changes follow circadian rhythms.
The number of WFA+ neurons generally peaks at zeitgeber time 20, when mice are awake,
and is lowest at zeitgeber time 6–8, when mice sleep [174]. These data suggest that PNN
composition may be regulated in a circadian manner to allow for circadian synaptic plastic-
ity, with PNN decrease during sleep favoring the synaptic refinement that is required for
memory consolidation [175]. For instance, during rapid eye movement (REM) sleep, mem-
ory representations are transferred from short-term storage sites, such as the hippocampus,
into long-term storage sites in neocortical areas, where they are strengthened, and short-
term storage memories are removed via synaptic pruning [176]. Indeed, sleep deprivation,
which is known to prevent synaptic modification that occurs in the hippocampus during
sleep [177,178], precludes a WFA-PNN decrease and leads to an increase in fear memory
extinction [174]. Alternatively, since PNNs are known to be important for protecting neu-
rons from oxidative stress [179–181], rhythms in PNN composition may reflect periods
of reduced oxidative stress during sleep. Indeed, following sleep deprivation, increased
oxidative stress in PV+ neurons is accompanied by an increase in the WFA labeling of
PNNs [182].
Dynamic PNN rearrangements are also reported after an injury to the CNS. For
instance, following unilateral damage to the labyrinth, which causes severe oculomotor
and postural symptoms, PNNs in the vestibular nuclei are initially reduced. Subsequently,
vestibular deficits usually resolve due to a process known as vestibular compensation,
where PNNs are reinstated, suggesting that a PNN decrease may allow for synaptic
remodeling to occur during vestibular compensation [183]. Moreover, PNNs are modulated
during injury-induced neuritic remodeling, such as in cortical areas affected by stroke [184],
in the denervated cerebellum [185], or after a spinal cord injury [186].
We can conclude that PNN expression can be altered in the adult CNS in conditions
in which plasticity is to be modulated. This is also the case during learning and memory
processes, which are discussed in the next section.
3.2. PNNs during Learning and Memory
Remarkable changes in PNNs occur during the formation and consolidation of memo-
ries, which are typical plasticity-based processes. The acquisition of auditory fear memory
is associated with an increase in PNNs in the hippocampus, auditory cortices, and ante-
rior cingulate cortex [187,188]. The formation of cerebellum-dependent motor-associative
memories is accompanied by a reduction in PNNs in cerebellar nuclei, followed by a
restoration of the PNNs when memories are consolidated [189]. Similarly, brevican in
PNNs surrounding hippocampal PV neurons is decreased during learning in the Morris
water maze and returns to baseline levels upon learning accomplishment [150]. An increas-
ing amount of evidence highlights changes in PNNs during the consumption of drugs of
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abuse (cocaine, heroin, nicotine, and alcohol) and drug-associated memories. Modulation
of the expression of PNN components is shown to depend on the type of drug, the duration
of drug exposure and withdrawal, and the brain region studied (for a review, see [190]).
For example, in the cerebellum, which is activated during exposure to drug-associated cues,
possibly to mediate the unconscious prediction of drug availability [191], WFA labeling
of PNNs is altered following cocaine administration [192–194]. Moreover, the formation
of cocaine-related preference memories is accompanied by the increased expression of
PNN-CSPGs around cerebellar Golgi neurons [195]. In the medial prefrontal cortex, which
is involved in drug-seeking, reinforcement-learning, and goal-directed behavior, long-term
abstinence from heroin self-administration is associated with a decrease in the protein lev-
els of several PNN constituents at the synapses, suggesting that changes in the ECM upon
the cessation of heroin self-administration may influence the relapse to drug seeking [196].
Acute cocaine exposure decreases WFA labeling in PNNs of the prefrontal cortex, whereas
repeated cocaine administration increases it [197]. Binge-like ethanol consumption in mice
induces an increased accumulation of CSPGs in PNNs around insular cortex neurons [198].
Since drug abuse induces an increase in reactive oxygen species in the brain [199], it can
be speculated that PNN changes following drug consumption are a consequence of oxida-
tive stress. Indeed, although PNNs are important for protecting neurons from oxidative
stress [179–181], they are themselves susceptible to it [180].
PNN modulation is not simply an epiphenomenon of learning and memory processes,
a causal link also exists between them (Figure 3). For instance, the manipulation of PNNs
in the hippocampus and cortex demonstrates that PNNs are crucial for consolidating
and/or maintaining long-term fear memories. Indeed, hyaluronidase injection in the
hippocampus before fear conditioning results in impaired contextual fear memory [200].
Similarly, following intrahippocampal infusions of ChABC and hyaluronidase prior to fear
conditioning training, rats show a profound impairment in contextual fear memory, but
no change in memory acquisition [201]. The injection of ChABC in the auditory cortex
or hippocampus of mice abolishes fear memory after fear conditioning, with no impact
on the fear learning process [187,188]. The digestion of PNNs in the secondary visual
cortex impairs the storage of remote visual fear memories [202]. Following increased PNN
expression in the hippocampus by overexpressing cartilage link protein 1, the recall of
remote fear memories is significantly enhanced [188]. PNNs are also implicated in the
consolidation of motor-associative memories, as the disruption of PNNs in the cerebellar
nuclei by ChABC impairs memory retention in the eyeblink conditioning paradigm [189].
In addition, PNNs are involved in the consolidation of memory of the environments in
which drugs are used, which is a crucial factor in triggering relapse to drug reuse. The role
of PNNs in drug addiction is further discussed in Section 4.2. As mentioned in Section 2.3,
the degradation of PNNs in the amygdala makes subsequently acquired fear memories
susceptible to erasure by extinction, pointing to a key role of PNNs in protecting fear
memories from erasure [95]. PNN removal in the perirhinal cortex or in the CA3, which are
important for object recognition memory, results instead in prolonged memory [76,165,203].
Only a few studies addressed the role of PNN in learning. Removing PNNs in
the auditory cortex by using hyaluronidase leads to increased reversal learning, i.e., the
ability to relearn a task that requires behavioral flexibility [47]. ChABC administration
in the cerebellar nuclei results in faster and better motor-associative learning [189,204].
In addition, the removal of PNNs in the hippocampus of mice showing impaired spatial
learning due to defective neuropeptide Y signaling reverses learning deficits [205]. Taken
together, these findings are consistent with the idea that PNN removal promotes plasticity.
Overall, PNNs appear to have a dual role: on the one hand, they can hamper new
learning by restricting plasticity, while on the other hand, they can protect memories by
stabilizing synaptic connections. Therefore, PNNs associated with specific populations of
neurons may be a potential target for therapeutic interventions aiming at either increasing
learning processes, potentiating adaptive memory, or erasing traumatic memories.
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3.3. Role of Metalloproteinases
The mechanisms underlying PNN modifications are far from clear. The decrease in
PNNs that occurs during plasticity-associated conditions may involve matrix-degrading en-
zymes. Many matrix metalloproteinases (MMPs) are released by neurons in response to ac-
tivity or during plasticity processes, including learning/memory (for a review, see [206,207]).
Many PNN components are known to be digested by MMPs and ADAMTSs (a disintegrin
and metalloproteinase with thrombospondin motifs) (for a review, see [208]). Indeed,
following an enriched environment, increases in MMP2 and -9 are observed in cerebellar
nuclei neurons that have low PNN expressions [164], and no decrease in cerebellar PNNs
is found in knockout mice for MMP9 [209]. The induction of ocular dominance plasticity
in adult mice by light reintroduction after dark exposure is associated with PNN degra-
dation, which is mediated by MMP9 [210]. MMP9 is also released in rodents during fear
conditioning [211]. Two other MMPs, namely, MMP3 and MMP13, are upregulated in
PV neurons after seizures [212]. Metalloproteinases belonging to the ADAMTS family,
namely, ADAMTS1 and ADAMTS4, degraded brevican in a rat model of epilepsy [213].
In addition, PV interneurons enwrapped in PNNs specifically expressed Adamts8 and
Adamts15 [214], suggesting that PNN-bearing neurons themselves are able to change
their surrounding matrix. Matrix metalloproteinases produced by microglia cells are also
involved in ECM/PNN remodeling. For example, cathepsis-S is a microglia-derived matrix
protease, which shows a diurnal rhythmic expression that is opposite to PNN rhythms.
The application of cathepsin-S to mouse brain sections eliminates WFA-PNN labeling,
suggesting that it may be crucially involved in circadian PNN modulation [174]. Microglia
cells are also able to engulf ECM molecules and clear them from the perisynaptic milieu,
where this process may contribute to experience-dependent synapse remodeling and mem-
ory consolidation [215]. Moreover, microglial dysfunction in the hippocampus results
in increased ECM expression and a reduction in dendritic spines [216]. In line with this
evidence, depletion of microglia leads to a substantially increased accumulation of PNNs in
the cortex and prevents the PNN loss that is found in the cortex in a model of Huntington’s
disease [217]. Thus, microglial cells might be crucial regulators of PNN maintenance, where
they are actively involved in the degradation of the ECM to allow for synaptic plasticity.
Although metalloproteinase activity may account for the rapid local changes in ECM
molecules that occur around synapses during plasticity-related events, changes in the syn-
thesis of PNN components and in CS-GAG sulfation patterns may also contribute to PNN
modulation in the adult brain, as it occurs during development and aging [51,56,164,187].
3.4. PNNs during Aging
Brain aging is characterized by a decline in sensory, motor, and cognitive functions,
and is associated with a progressive reduction in neural plasticity. Hence, an increase
in PNN expression during aging is expected. Although contrasting evidence has been
presented, there is a general agreement that this is indeed the case. In middle-aged mice
(12 months old), the density of WFA+ PNNs in the somatosensory and visual cortex is
increased in comparison to that in young adults (3 months old), particularly around GABA-
negative neurons [218]. In another study, the PNN-WFA intensity in the dorsal part of
the hippocampus is reduced in the CA1 region, whereas it is not changed in the CA3
region, and is increased in the dentate gyrus when compared to 2-month-old mice. No
significant aging-related changes in PNN-WFA intensity have been detected in the ventral
hippocampus [31]. However, in older mice (18 months of age), a substantial increase in WFA
staining in both PNNs and the diffuse ECM is detected in the whole hippocampus when
compared to young animals (3 months of age), and strong age-dependent upregulation of
ECM proteins, such as cartilage link protein 1, brevican, and neurocan, in hippocampal
synaptosomes is found [219]. In primary sensory cortices, but not in associative cortices,
the number of neurons surrounded by a PNN is increased in 12-month-old mice when
compared to 2-month-old mice [220]. A substantial increase in perineuronal aggrecan
staining is reported in the pre-frontal cortex and the hippocampal CA3 area of very old
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rats (24 months old) [221]. In the striatum, CSPGs accumulate in PNNs and the diffuse
ECM in an aging-dependent manner, and ChABC administration in aged mice significantly
improves age-related motor deficits [222].
An age-dependent increase in perineuronal/perisynaptic ECM levels may well con-
tribute to cognitive and motor impairments during aging by reducing molecular and
cellular signaling mechanisms that are normally required for plasticity to occur.
When studying the expression levels of CS-GAGs, Foscarin et al. [56] found that the
total amount of GAGs isolated from the general diffuse brain matrix and the PNN matrix
of rats are stable with age. The amounts of C4S and C6S in the diffuse ECM also remain
stable in the aged brain (12 and 18 months of age) when compared to young brains, but
C6S in the PNN fraction are strongly reduced, leading to an increase in the C4S/C6S ratio.
In addition, the late loss of C6S in the aged brain makes PNNs more inhibitory to neurite
growth than in the young brain, as the 18-month PNN-GAGs are more inhibitory than
3-month PNN-GAGs in vitro [56]. These data point to important changes in PNN-GAG
sulfation in aged brains, which may be responsible for the plasticity decline and memory
impairments that are typically found in aged individuals.
4. PNNs and Memory-Related Diseases
In the last decade, several studies focused on the relationship between PNNs and
various brain diseases, including schizophrenia, epilepsy, depression, multiple sclerosis,
and Huntington’s disease [217,223–226]. Here, we address PNN changes and their roles
in two widespread memory-related diseases, namely Alzheimer’s disease (AD), in which
memory formation is compromised, and drug addiction, in which maladaptive memories
are present.
4.1. PNNs in Alzheimer’s Disease
AD is a progressive neurodegenerative disease that affects the neocortex and hip-
pocampus and is characterized by impaired learning and retrieval of memories. Two
hallmarks of AD are extraneuronal deposition of the amyloid-beta protein in the form of
plaques and intraneuronal aggregation of the microtubule-associated protein tau in the
form of filaments [227,228]. Some studies document a partial loss of CS-GAGs/CSPGs
in the PNNs of patients and mouse models of AD, particularly in the cingulate, frontal,
temporal, and entorhinal cortexes [224,229,230] and middle frontal gyrus [231] in humans,
and in the hippocampus CA1, CA2, and CA3 [232], subiculum, and visual cortex [231] in
mice. However, other studies report no alteration of PNNs in the brains of AD patients or
mice in the human insular cortex and subcortical regions [233]; human primary sensory,
secondary, and associative areas of the temporal and occipital lobe [234]; mouse parietal
cortex [233]. A recent study pointed to an intriguing role of microglia activation, triggered
by amyloid plaques, in mediating extensive PNN loss in a mouse model of AD [231]. While
there are no studies reporting a PNN increase in human AD brains, mice characterized by
amyloid-beta plaque production (APP/PS1 mice) show increased WFA labeling around
hippocampal PV neurons and the upregulation of several ECM proteins in hippocampal
synaptosome preparations at early stages (3 months of age), when amyloid-beta plaques
are not yet observed, but when contextual fear memory is impaired and long-term poten-
tiation (LTP) is reduced. These physiological and behavioral deficits are reversed when
the ECM/PNNs are removed by ChABC, indicating that perisynaptic ECM accumulation
may contribute to early memory and plasticity impairments in AD [235]. Interestingly,
PNNs may protect neurons and synapses from amyloid toxicity, as shown in vitro [236],
and from tau pathology [233,237]. Direct evidence for a role of PNN in neuroprotection is
shown in the study by Suttkus et al. [238]. When exogenous tau protein is added to brain
organotypic cultures, it is mainly internalized in neurons without a PNN. However, if the
PNN is disrupted due to the lack of aggrecan, link protein 1, or tenascin-R, tau becomes
internalized in PNN neurons as well. Membrane-associated heparan sulfate proteoglycans
have been shown to induce the internalization of tau aggregates [239]. PNNs may bind
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tau aggregates (possibly through the large polyanionic molecule aggrecan), therefore in-
hibiting their interaction with the heparan sulfate proteoglycans and, as a consequence,
their internalization.
In order to overcome the progressive loss of functional connections due to neurode-
generation in AD, new connections may help bypass nonfunctional neurons, leading to
functional improvements. To help form new connections, the degradation of PNNs may be
beneficial. In the study by Yang et al. [240], the digestion of PNNs in the perirhinal cortex
of AD mice with neurodegenerative tauopathy, in which object memory decays rapidly,
results in restoration of normal synaptic transmission and behavioral amelioration. As
highlighted above (see Section 2.2), the sulfation pattern of CS-GAGs affects CSPG binding
properties and function, with 4-sulfated CS-GAGs being inhibitory to neurite growth. Inter-
estingly, in tauopathy mice, the administration of antibodies blocking 4-sulfated CS-GAGs
in the perirhinal cortex is sufficient to restore object memory [123].
Overall, there is some discrepancy between studies investigating PNN changes in AD
human tissue, as well as in mouse models, with some studies reporting no changes and
others reporting a PNN reduction. These differences in mice may depend on the mouse
genetic background, and in humans, on the disease stage, the brain area investigated,
the age of the patient, and technical issues. Moreover, AD mouse models do not always
match with the human pathology, as PNN expression is increased in some mouse models
of AD, whereas in human AD brains, PNNs are mostly decreased or unchanged. Given
the important role of sulfation patterns in PNN functions, it would be interesting to
address whether PNN sulfation in brain regions affected by AD is different from that of
healthy subjects. PNN sulfation pattern can be a potential therapeutic target for improving
AD symptoms.
PNNs are shown to have a neuroprotective role against tau pathology. However, ben-
eficial effects on memory were obtained by acute PNN disruption in tauopathy mice [240].
Further studies are needed to elucidate the synaptic/anatomical changes underlying mem-
ory restoration, as well as long-term effects, following PNN manipulation in AD mice.
Moreover, in view of developing therapeutic strategies, the dual role of PNNs in neuropro-
tection and the restriction of plasticity should be taken into account.
4.2. PNNs and Drug Addiction
Drug addiction is considered a chronic relapsing disorder, in which craving and re-
lapse to drug seeking occur even after prolonged abstinence [241]. This is because addiction
involves many of the same brain circuits that govern learning and memory. Exposure
to environmental stimuli that have previously been associated with the effects of self-
administered drugs is often a major contributor to relapse, as it evokes memories of the
effects of the drug [241,242]. Given the role of PNNs in learning and memory processes, in-
cluding associative memories, it is not surprising that PNNs are not only altered following
drug consumption or during addiction (see above) but also play an active role in the consol-
idation of addiction memories [190,243]. Memories of drug-associated environmental cues
are assessed using the conditioned place preference test, in which animals learn to associate
the environment in which they received the drug with the internal positive state achieved
while on the drug, and thus spend more time in the drug-paired compartment, even in the
absence of the drug. In rats that received a ChABC injection in the prelimbic cortex or the
anterior dorsal region of the lateral hypothalamus before conditioning, the development
of a cocaine-conditioned place preference is attenuated, indicating that PNNs in those
brain regions are important for memories of drug–environment associations [244,245].
Moreover, PNNs in the anterior dorsal region of the lateral hypothalamus are instrumental
for the expression of the cue-induced reinstatement of cocaine-seeking behavior [246].
Interestingly, when ChABC is injected into the prefrontal cortex after extinction, but before
the reactivation of the cocaine memory, the preference for the cocaine-paired chamber is
attenuated, suggesting that PNNs are also important for memory reconsolidation [244].
In accordance with the results shown by Gogolla et al. [95], in which the reinstatement
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of a fear memory is reduced after ChABC injection in the amygdala, PNN digestion in
the amygdala enables extinction training to erase drug memories, attenuating the rein-
statement of morphine-induced and cocaine-induced conditioned-place preference [247].
Together, these observations highlight a crucial role of PNNs in memory of drug-associated
environments and suggest that targeting PNNs might be a therapeutic strategy to suppress
these maladaptive memories and prevent relapse to drug use.
5. Conclusions
Although at the time of their first detection, PNNs did not receive much attention,
being considered as mere staining artifacts, later they were recognized as an integral part of
the brain maturation process, especially with the unexpected discovery of a link between
PNNs and brain plasticity [86]. In the adult brain, PNNs turned out to be more dynamic
than initially thought, and they took center stage in what is considered to be one of the great
mysteries of neuroscience, namely, how memories are encoded in the brain [95,248,249].
To get a better understanding of PNN dynamics, however, the production of tools
allowing for live PNN imaging would be required. This way, temporal changes in the
structure and expression of PNNs in vivo, for instance, during learning and memory,
might be unveiled. Furthermore, developing molecular tools (vectors, antibodies, peptides,
antagonists, etc.) to specifically interfere with PNN components would be beneficial to
further our understanding of PNN functions and, in view of designing therapeutic tools,
to improve certain CNS conditions. Most studies have used ChABC to remove PNN-
GAG chains and increase CNS plasticity. However, in the context of human therapy, this
approach is not feasible, as multiple injections of the enzyme would be needed to target
large volumes of the human brain and to ensure a long-term supply of it. The delivery of
ChABC via viral vectors, which can ensure a cell-type-specific and continuous delivery
of the enzyme, may be a promising strategy to overcome those issues [189,250–252]. The
recent development of an immune-evasive and time-regulatable ChABC gene therapy
system [253] is a further step in this direction. It has to be noted, though, that ChABC
treatment affects PNNs, as well as diffuse and membrane-bound CS-GAGs, and is therefore
not ideal when there is the need to specifically target PNNs. Even when targeting PNN-
CSPGs, ChABC can be considered a crude intervention, as it affects all CS-GAGs and, in
turn, CSPG-binding partners, which may play distinct roles in the control of plasticity.
Therefore, targeting specific components of the PNN seems a better approach. Potentially
interesting candidates in this respect are Sema3A and Otx2. Further studies are needed to
unravel their precise role in physiological conditions, such as during learning and memory
or the aging process, as well as in pathological conditions. In addition, given the crucial
role played by specific sulfated CS-GAGs in PNN binding properties and the regulation of
plasticity, memory, and aging, targeting the sulfation pattern of CS-GAGs may be another
strategy to delicately manipulate PNNs.
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